These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Direct Reprogramming of Human DMD Fibroblasts into Myotubes for In Vitro Evaluation of Antisense-Mediated Exon Skipping and Exons 45-55 Skipping Accompanied by Rescue of Dystrophin Expression. Lee JJA; Saito T; Duddy W; Takeda S; Yokota T Methods Mol Biol; 2018; 1828():141-150. PubMed ID: 30171539 [TBL] [Abstract][Full Text] [Related]
5. Biochemical characterization of patients with in-frame or out-of-frame DMD deletions pertinent to exon 44 or 45 skipping. Anthony K; Arechavala-Gomeza V; Ricotti V; Torelli S; Feng L; Janghra N; Tasca G; Guglieri M; Barresi R; Armaroli A; Ferlini A; Bushby K; Straub V; Ricci E; Sewry C; Morgan J; Muntoni F JAMA Neurol; 2014 Jan; 71(1):32-40. PubMed ID: 24217213 [TBL] [Abstract][Full Text] [Related]
6. Systemic administration of the antisense oligonucleotide NS-065/NCNP-01 for skipping of exon 53 in patients with Duchenne muscular dystrophy. Komaki H; Nagata T; Saito T; Masuda S; Takeshita E; Sasaki M; Tachimori H; Nakamura H; Aoki Y; Takeda S Sci Transl Med; 2018 Apr; 10(437):. PubMed ID: 29669851 [TBL] [Abstract][Full Text] [Related]
7. Viltolarsen for the treatment of Duchenne muscular dystrophy. Roshmi RR; Yokota T Drugs Today (Barc); 2019 Oct; 55(10):627-639. PubMed ID: 31720560 [TBL] [Abstract][Full Text] [Related]
8. Exons 45-55 Skipping Using Antisense Oligonucleotides in Immortalized Human DMD Muscle Cells. He M; Yokota T Methods Mol Biol; 2023; 2640():313-325. PubMed ID: 36995604 [TBL] [Abstract][Full Text] [Related]
9. Rescue of dystrophin mRNA of Duchenne muscular dystrophy by inducing exon skipping. Matsuo M; Takeshima Y Acta Myol; 2005 Oct; 24(2):110-4. PubMed ID: 16550927 [TBL] [Abstract][Full Text] [Related]
10. Bioinformatic and functional optimization of antisense phosphorodiamidate morpholino oligomers (PMOs) for therapeutic modulation of RNA splicing in muscle. Popplewell LJ; Graham IR; Malerba A; Dickson G Methods Mol Biol; 2011; 709():153-78. PubMed ID: 21194027 [TBL] [Abstract][Full Text] [Related]
11. Dystrophin quantification and clinical correlations in Becker muscular dystrophy: implications for clinical trials. Anthony K; Cirak S; Torelli S; Tasca G; Feng L; Arechavala-Gomeza V; Armaroli A; Guglieri M; Straathof CS; Verschuuren JJ; Aartsma-Rus A; Helderman-van den Enden P; Bushby K; Straub V; Sewry C; Ferlini A; Ricci E; Morgan JE; Muntoni F Brain; 2011 Dec; 134(Pt 12):3547-59. PubMed ID: 22102647 [TBL] [Abstract][Full Text] [Related]
14. Nonclinical Exon Skipping Studies with 2'-O-Methyl Phosphorothioate Antisense Oligonucleotides in mdx and mdx-utrn-/- Mice Inspired by Clinical Trial Results. van Putten M; Tanganyika-de Winter C; Bosgra S; Aartsma-Rus A Nucleic Acid Ther; 2019 Apr; 29(2):92-103. PubMed ID: 30672725 [TBL] [Abstract][Full Text] [Related]
15. In Vivo Evaluation of Multiple Exon Skipping with Peptide-PMOs in Cardiac and Skeletal Muscles in Dystrophic Dogs. Maruyama R; Aoki Y; Takeda S; Yokota T Methods Mol Biol; 2018; 1828():365-379. PubMed ID: 30171554 [TBL] [Abstract][Full Text] [Related]
16. Exon skipping for Duchenne muscular dystrophy: a systematic review and meta-analysis. Shimizu-Motohashi Y; Murakami T; Kimura E; Komaki H; Watanabe N Orphanet J Rare Dis; 2018 Jun; 13(1):93. PubMed ID: 29907124 [TBL] [Abstract][Full Text] [Related]
17. Eteplirsen treatment for Duchenne muscular dystrophy: Exon skipping and dystrophin production. Charleston JS; Schnell FJ; Dworzak J; Donoghue C; Lewis S; Chen L; Young GD; Milici AJ; Voss J; DeAlwis U; Wentworth B; Rodino-Klapac LR; Sahenk Z; Frank D; Mendell JR Neurology; 2018 Jun; 90(24):e2146-e2154. PubMed ID: 29752304 [TBL] [Abstract][Full Text] [Related]
18. Exons 45-55 Skipping Using Mutation-Tailored Cocktails of Antisense Morpholinos in the DMD Gene. Echigoya Y; Lim KRQ; Melo D; Bao B; Trieu N; Mizobe Y; Maruyama R; Mamchaoui K; Tanihata J; Aoki Y; Takeda S; Mouly V; Duddy W; Yokota T Mol Ther; 2019 Nov; 27(11):2005-2017. PubMed ID: 31416775 [TBL] [Abstract][Full Text] [Related]